All News #Library
Biotech
Vividion Publishes WRN Inhibitor VVD-214 in J. Med. Chem
06 Jan 2026 //
BUSINESSWIRE
Vividion Unveils First-in-Class KEAP1 Activator for Oncology
22 Dec 2025 //
BUSINESSWIRE
Bayer Bails On Vividion Tumor Drug In Early-Stage Clear-Out
12 Nov 2025 //
FIERCE BIOTECH
Vividion secures clinical-stage WRN inhibitor from Roche
04 Jun 2025 //
FIERCE BIOTECH
Vividion Therapeutics Doses First Patient in RAS-PI3K Inhibitor
03 Apr 2025 //
BUSINESSWIRE
Vividion Acquires Tavros To Enhance Functional Genomics Platform
08 Jan 2025 //
BUSINESSWIRE
Tavros achieves milestones in collaboration with Bayer’s Vividion
14 May 2024 //
BIOSPACE

Market Place
Sourcing Support